NEWS
RESEARCH MONEY: Life sciences organizations ask Ottawa for national strategy following Sanofi investment
Read Original Article Here BioNova has added its voice alongside a group of 18 other health sciences and business associations asking for a national life sciences strategy and increased collaboration. The online campaign, led by Life Sciences Ontario, began with an...
THE HILL TIMES: New life sciences campaign aims to break down silos between innovation, economic development and health policies
The Hill Times: April 12, 2021 New life sciences campaign aims to break down silos between innovation, economic development and health policies By: Tessie Sanci A new public-facing campaign launched on April 12 is asking federal politicians to work on a national life...
Sona Nanotech Closes Unbrokered Private Placement Financing for $2.26m in Gross Proceeds
Read Orginal Article Here December 16, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”, “Sona”) a developer of rapid, point-of-care diagnostic tests, is pleased to announce that it has closed its non-brokered private placement...
Motryx announces partnership with Aerocom
Read Original Article Simple and reliable validation of Pneumatic Tube Systems for blood sample integrity monitoring Halifax, Canada, December 2020 – Motryx, provider of blood transport validation and verification services, today announced a partnership with Aerocom,...
NEWS RELEASE – BioNova Announces Swiftsure Innovations as the Winner of the Tenth Annual BioInnovation Challenge (BIC) at BioPort 2020
FOR IMMEDIATE RELEASE November 4, 2020 BioNova Announces Swiftsure Innovations as the Winner of the Tenth Annual BioInnovation Challenge (BIC) at BioPort 2020 Halifax, NS – November 4, 2020 – Today Swiftsure Innovations from Newfoundland was named the winner of...
EVENTS
SOCIAL
ICYMI: BioNova members @BioMedica_NS were featured in @NSBI's virtual reality video, highlighting several innovative #NovaScotia businesses. Take a virtual tour of BioMedica's facility at the 5:18 mark: https://t.co/kBtXiZ0UkH
BioNova members @imv_inc will be launching a phase 1B clinical trial for their lead immunotherapy (maveropepimut-S) to be investigated in patients with breast cancer at the Providence Cancer Institute in Oregon 🔬. The clinical trial is expected to begin this summer. Read more ⬇️ https://t.co/DppxfflZ2h
Dartmouth-based #biotech company IMV says its lead compound, known as maveropepimut-S, will be trialed in patients with hormone receptor positive/HER2-negative #breastcancer. https://t.co/tRdeCf1Ejd https://t.co/cHIRoBEym7
ABOUT BIONOVA
Our mandate is to:
- LEAD the development of Health and Life Science in Nova Scotia
- ACCELERATE companies and the business ecosystem
- ADVOCATE for the sector and growth of Nova Scotia’s BioEconomy
OUR SECTOR STRENGTHS
Medical Technologies- Digital Health
- Pharmaceuticals & Vaccines
- Natural Health Products
- BioProducts
Medical Technologies
Digital Health
Pharmaceuticals & Vaccines
Natural Health Products
BioProductsPlease visit our Sector Strengths page to learn more.
OUR ACCELERATION INITIATIVES
BioNova aims to accelerate the innovation and productivity of businesses in Nova Scotia’s bioeconomy through our Projects, Programs, Services & Events with the support of our stakeholders and funding partners.